Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Our Stevenage facility offers dedicated cell therapy clinical trial support services and is a key collaborator in the Cell & Gene Therapy Catapult (CGT) "Manufacturing Operation Forum."
This 80,000 sq. ft. cell therapy manufacturing facility is projected to produce over 150,000 doses of cell therapy by 2023.
The Thermo Fisher Scientific Stevenage "CryoHub" will serve as the central storage and distribution facility in support of CGT collaborators as well as other pharma / biopharma manufacturers.
Download the site capabilities fact sheet to learn more about this location.